Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer

Reproductive Sciences

Volumn 19, Issue 7, 2012, Pages 748-753

  Zhao, M ^a   Shen, F ^b   Yin, Y X ^a   Yang, Y Y ^a   Xiang, D J ^a   Chen, Q ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

epithelial ovarian cancer; HSP27; peritoneal metastasis

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PERITONEAL NEOPLASMS; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84863527755     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111432875     Document Type: Article

References (33)

1. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Nat Cancer Inst. 2005 ; 97 (17). 1407
2. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996 ; 334 (1). 1-6
3. Chow SN, Chen RJ, Chen CH, et al. Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology. Eur J Gynaecol Oncol. 2010 ; 31 (1). 55-62
4. Cohen M, Dromard M, Petignat P. Heat shock proteins in ovarian cancer: a potential target for therapy. Gynecol oncol. 2010 ; 119 (1). 164-166
5. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999 ; 11 (1). 1
6. Mattila K, Valtonen V, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin infect dis. 1998 ; 26 (3). 719
7. Tang D, Khaleque MA, Jones EL, et al. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005 ; 10 (1). 46
8. Elpek GÖ, Karaveli IM, Ek T, Kele N, Aksoy NH. Expression of heat shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS. 2003 ; 111 (4). 523-530
9. Arts HJG, Hollema H, Lemstra W, et al. Heat shock protein 27 (HSP27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J cancer. 1999 ; 84 (3). 234-238
10. Sarto C, Binz PA, Mocarelli P. Heat shock proteins in human cancer. Electrophoresis. 2000 ; 21 (6). 1218-1226
11. Olejek A, Damasiewicz-Bodzek A, Bodzek P, et al. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma. Int J Gynecol Cancer. 2009 ; 19 (9). 1516
12. Rui Z, Jian Guo J, Yuan Peng T, Hai P, Bing Gen R. Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics. 2003 ; 3 (4). 433-439
13. Vargas-Roig LM, Fanelli MA, Lopez LA, et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev. 1997 ; 21 (5). 441
14. Alaiya AA, Franzén B, Moberger B, Silfverswärd C, Linder S, Auer G. Two dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity. Electrophoresis. 1999 ; 20 (4-5). 1039-1046
15. Jiang D, Ying W, Lu Y, et al. Identification of metastasis associated proteins by proteomic analysis and functional exploration of interleukin 18 in metastasis. Proteomics. 2003 ; 3 (5). 724-737
16. Kim J, Kim SH, Lee SU, et al. Proteome analysis of human liver tumor tissue by two dimensional gel electrophoresis and matrixassisted laser desorption/ionization mass spectrometry for identification of disease related proteins. Electrophoresis. 2002 ; 23 (24). 4142-4156
17. Adams DJ, Hajj H, Edwards DP, Bjercke RJ, McGuire WL. Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer res. 1983 ; 43 (9). 4297
18. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev. 1992 ; 11 (2). 197-220
19. Love S, King R. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J cancer. 1994 ; 69 (4). 743
20. Foster C, Dodson A, Ambroisine L, et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J cancer. 2009 ; 101 (7). 1137-1144
21. Morino M, Tsuzuki T, Ishikawa Y, et al. Specific regulation of HSPs in human tumor cell lines by flavonoids. In Vivo. 1997 ; 11 (3). 265
22. Lemieux P, Oesterreich S, Lawrence J, et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis. 1997 ; 17 (3). 113
23. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SAW. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 1993 ; 53 (19). 4443
24. Annunziata CM, Kleinberg L, Davidson B, et al. BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. Clin Cancer Res. 2007 ; 13 (22). 6585
25. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005 ; 10 (2). 86
26. Melle C, Ernst G, Escher N, et al. Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin chem. 2007 ; 53 (4). 629
27. Beere HM. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Investigation. 2005 ; 115 (10). 2633
28. Elstrand MB, Kleinberg L, Kohn EC, Trope CG, Davidson B. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int J Gynecol Pathol. 2009 ; 28 (3). 211-221
29. Fujiwara K, Shirafuji H, Fushitani K, Fujimoto K, Kohno I, Modest E. Change in the localization of heat shock protein 27 (HSP 27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3. Anticancer Res. 1999 ; 19 (1A). 181-187
30. Marin R, Tanguay R. Stage-specific localization of the small heat shock protein Hsp27 during oogenesis inDrosophila melanogaster. Chromosoma. 1996 ; 105 (3). 142-149
31. Robitaille H, Simard-Bisson C, Larouche D, Tanguay RM, Blouin R, Germain L. The small heat-shock protein Hsp27 undergoes ERK-dependent phosphorylation and redistribution to the cytoskeleton in response to dual leucine zipper-bearing kinase expression. J Invest Dermatol. 2009 ; 130 (1). 74-85
32. Jiang Y, Woronicz JD, Liu W, Goeddel DV. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 1999 ; 283 (5401). 543
33. Miki K, Eddy EM. Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain. Mol Cell Biol. 2002 ; 22 (8). 2536